Future Science Group, founded in 2001, is independently owned.
Future Science Group’s portfolio consists of two imprints, Future Medicine and Future Science. Both publish books and journals. In addition to this core publishing business, Future Science Group develops specialist community-driven websites. Key titles and sites include MedChemNet, Future Microbiology, Future Virology and the award-winning Regenerative Medicine.
The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.
Learn more about Future Science Group here.